Camillo Ribi

5.4k total citations · 1 hit paper
111 papers, 3.3k citations indexed

About

Camillo Ribi is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Camillo Ribi has authored 111 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Rheumatology, 34 papers in Immunology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Camillo Ribi's work include Systemic Lupus Erythematosus Research (34 papers), Vasculitis and related conditions (15 papers) and Drug-Induced Adverse Reactions (11 papers). Camillo Ribi is often cited by papers focused on Systemic Lupus Erythematosus Research (34 papers), Vasculitis and related conditions (15 papers) and Drug-Induced Adverse Reactions (11 papers). Camillo Ribi collaborates with scholars based in Switzerland, France and United States. Camillo Ribi's co-authors include Olivier Michielin, François Spertini, Michel Obéid, Solange Peters, Montserrat Fraga, Thierry Küntzer, Gerasimos P. Sykiotis, George Coukos, Michel H. Maillard and Filipe Martins and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Camillo Ribi

100 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

2019 1.5k citations Filipe Martins, Sofiya Latifyan et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Camillo Ribi Switzerland	22	1.4k	996	910	898	366	111	3.3k
James B. Whitmore United States	25	817 0.6×	726 0.7×	749 0.8×	1.5k 1.7×	519 1.4×	63	4.0k
Yan Guex‐Crosier Switzerland	26	1.3k 0.9×	495 0.5×	245 0.3×	567 0.6×	335 0.9×	131	3.6k
Freda Passam Australia	31	592 0.4×	469 0.5×	472 0.5×	658 0.7×	780 2.1×	97	3.2k
Edward W. Cowen United States	31	567 0.4×	426 0.4×	389 0.4×	852 0.9×	507 1.4×	155	3.2k
Jason Jungsik Song South Korea	27	307 0.2×	722 0.7×	921 1.0×	468 0.5×	695 1.9×	215	2.7k
Vincent Audard France	35	1.2k 0.8×	980 1.0×	323 0.4×	447 0.5×	906 2.5×	182	4.8k
A. Mékinian France	38	365 0.3×	1.2k 1.2×	1.4k 1.6×	1.1k 1.3×	478 1.3×	231	4.4k
Shigeto Tohma Japan	33	354 0.2×	409 0.4×	1.6k 1.8×	968 1.1×	578 1.6×	182	3.5k
Kirk R. Schultz Canada	45	1.3k 0.9×	631 0.6×	281 0.3×	1.8k 2.0×	770 2.1×	214	7.4k
Tracy I. George United States	34	492 0.3×	330 0.3×	956 1.1×	1.6k 1.8×	497 1.4×	177	3.6k

Countries citing papers authored by Camillo Ribi

Since Specialization

Citations

This map shows the geographic impact of Camillo Ribi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camillo Ribi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camillo Ribi more than expected).

Fields of papers citing papers by Camillo Ribi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camillo Ribi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camillo Ribi. The network helps show where Camillo Ribi may publish in the future.

Co-authorship network of co-authors of Camillo Ribi

This figure shows the co-authorship network connecting the top 25 collaborators of Camillo Ribi. A scholar is included among the top collaborators of Camillo Ribi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camillo Ribi. Camillo Ribi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klehr, Juliane, Laura Infanti, Carlo Chizzolini, et al.. (2024). Factor H-related protein 1 in systemic lupus erythematosus. Frontiers in Immunology. 15. 1447991–1447991. 3 indexed citations

Halfon, Matthieu, Aurel T. Tankeu, & Camillo Ribi. (2024). Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis. International Journal of Molecular Sciences. 25(11). 6162–6162. 16 indexed citations

Chizzolini, Carlo, Jean‐Charles Guéry, Fanny Noulet, et al.. (2024). Extrafollicular CD19lowCXCR5−CD11c− double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosus. Journal of Translational Autoimmunity. 9. 100252–100252. 4 indexed citations

Ribi, Camillo, et al.. (2023). OP0020 THE CELLULAR METABOLISM OF SLE NK CELLS IS PRIMARILY ALTERED AT THE LEVEL OF MITOCHONDRIAL HOMEOSTASIS. Annals of the Rheumatic Diseases. 82. 13–13. 1 indexed citations

Iudici, Michele, Mihaela Stegert, Sabine Adler, et al.. (2023). Management of giant-cell arteritis in Switzerland: an online national survey. Swiss Medical Weekly. 153(4). 40051–40051.

Ribi, Camillo, Carlo Chizzolini, Marten Trendelenburg, et al.. (2023). Worse cardiovascular and renal outcome in male SLE patients. Scientific Reports. 13(1). 18628–18628. 12 indexed citations

Bodmer, Nicolas S., Lucas M. Bachmann, Camillo Ribi, et al.. (2021). Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study. Lupus. 30(10). 1565–1576. 19 indexed citations

Moi, Laura, M Hamédani, & Camillo Ribi. (2021). Long‐term outcomes in corticosteroid‐refractory Graves' orbitopathy treated with tocilizumab. Clinical Endocrinology. 97(3). 363–370. 19 indexed citations

Guex‐Crosier, Yan, et al.. (2021). When obstetrics–gynecology specialists need to call an ophthalmologist urgently: a case report. Journal of Medical Case Reports. 15(1). 517–517. 1 indexed citations

10.

Lafarge, Antoine, Adrien Joseph, Christian Pagnoux, et al.. (2019). Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group. Lara D. Veeken. 59(9). 2250–2257. 14 indexed citations

11.

Martins, Filipe, Sofiya Latifyan, Gerasimos P. Sykiotis, et al.. (2019). Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nature Reviews Clinical Oncology. 16(9). 563–580. 1544 indexed citations breakdown →

12.

Chalikias, Georgios, Dimitrios Tziakas, Carlo Chizzolini, et al.. (2018). Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus. PLoS ONE. 13(1). e0188695–e0188695. 12 indexed citations

13.

Ribi, Camillo, Carlo Chizzolini, Uyen Huynh‐Do, et al.. (2017). Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus. Nephrology Dialysis Transplantation. 33(1). 54–64. 12 indexed citations

14.

Bergmann, Marcel M., et al.. (2014). Anaphylaxie aux colorants bleus. Archive ouverte UNIGE (University of Geneva). 1 indexed citations

15.

Ribi, Camillo, Marten Trendelenburg, Angèle Gayet‐Ageron, et al.. (2014). The Swiss Systemic lupus erythematosus Cohort Study (SSCS) – cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland. Swiss Medical Weekly. 144(3132). w13990–w13990. 28 indexed citations

16.

Feldmeyer, Laurence, et al.. (2013). Formes sévères d’hypersensibilité médicamenteuse retardée. Revue Médicale Suisse. 9(382). 803–811. 1 indexed citations

17.

Ribi, Camillo, et al.. (2012). Atteintes [b]neurologiques[/b] centrales du lupus érythémateux systémique. Revue Médicale Suisse. 8(337). 848–853. 1 indexed citations

18.

Ribi, Camillo, et al.. (2010). La polychondrite chronique atrophiante. Archive ouverte UNIGE (University of Geneva).

19.

Chizzolini, Carlo, Clemens D. Cohen, Ute Eisenberger, et al.. (2009). [Towards the Swiss systemic lupus erythematosus cohort study (SSCS)].. PubMed. 5(199). 808–11. 12 indexed citations

20.

Ribi, Camillo & Carl J. Hauser. (2002). Adverse reactions to pyrazinamide. Allergy. 57(10). 964–965. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact